Lux Biosciences to Present at Lazard Capital Markets 6th Annual Healthcare Conference
Published: Nov 16, 2009
JERSEY CITY, N.J.--(BUSINESS WIRE)--Lux Biosciences, Inc., a privately held biotechnology company specialized in the field of ophthalmic diseases, announced today that Brett Skolnik, Chief Financial Officer, will present a company overview at the Lazard Capital Markets 6th Annual Healthcare Conference on Wednesday, November 18th, 2009 at 10:00 a.m. ET. The conference is ongoing November 17–19 at the St. Regis Hotel, New York City.